Myocardial Infarction in a Patient With Homozygous Plasminogen Activator Inhibitor-1 (PAI-1) 4G/4G Mutation: A Case Report. [PDF]
Manasrah A +4 more
europepmc +1 more source
A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles. [PDF]
Wortley J +4 more
europepmc +1 more source
Neuronal conversion of single-chain tissue-type plasminogen activator into its two-chain form: implications in neurodevelopment, learning, and memory. [PDF]
Triniac H +6 more
europepmc +1 more source
Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. [PDF]
Wang H, Huang C.
europepmc +1 more source
One-Year Outcomes After Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke: A Real-World Study. [PDF]
Xue R +10 more
europepmc +1 more source
Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation [PDF]
Bontempo, FA +5 more
core
Successful Intraluminal Administration of Tissue Plasminogen Activator for Life-Threatening Obstructive Hematoma in Extremely Preterm Infants. [PDF]
Kim SH +6 more
europepmc +1 more source
Tissue-type plasminogen activator expression by endothelial cells and oligodendrocytes is required for proper CNS myelination. [PDF]
Delaunay-Piednoir B +8 more
europepmc +1 more source
Cardiogenic Embolism Treated Successfully by Intravenous Recombinant Tissue-Type Plasminogen Activator Administration in a Young Child With Congenital Heart Disease: A Case Report. [PDF]
Kurihara K +4 more
europepmc +1 more source

